63909-58-0

Basic information

• Product Name: (4-FLUOROBENZYL)PHOSPHONIC ACID DIETHYL ESTER
• Synonyms: ETHYL 4-FLUOROBENZYLPHOSPHONATE;DIETHYL (4-FLUOROBENZYL)PHOSPHONATE;(4-FLUOROBENZYL)PHOSPHONIC ACID DIETHYL ESTER;[(4-Fluorophenyl)methyl]phosphonic acid diethyl ester;Diethyl (p-fluorophenyl)methanephosphonate;Phosphonic acid, [(4-fluorophenyl)methyl]-, diethyl ester
• CAS NO: 63909-58-0
• Molecular Formula: C₁₁H₁₆FO₃P
• Molecular Weight: 246.22
• Mol File: 63909-58-0.mol

Chemical Properties

• Boiling Point: 150 °C / 6mmHg
• Flash Point: >110℃
• Appearance: /
• Density: 1.16
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: n20/D1.483
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: (4-FLUOROBENZYL)PHOSPHONIC ACID DIETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: (4-FLUOROBENZYL)PHOSPHONIC ACID DIETHYL ESTER(63909-58-0)
• EPA Substance Registry System: (4-FLUOROBENZYL)PHOSPHONIC ACID DIETHYL ESTER(63909-58-0)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 63909-58-0(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
(4-Fluorobenzyl)phosphonic acid diethyl ester is used as a key intermediate in the synthesis of various pharmaceuticals, agrochemicals, and insecticides, due to its unique chemical properties and reactivity.
Used in Flame-Retardant Materials:
In the industry of flame-retardant materials, (4-Fluorobenzyl)phosphonic acid diethyl ester serves as a phosphorus source, contributing to the development of materials with enhanced fire-resistant properties.
Used in Specialty Chemicals Production:
(4-FLUOROBENZYL)PHOSPHONIC ACID DIETHYL ESTER is utilized in the production of specialty chemicals, where its specific characteristics are leveraged to create high-value products for various applications.
Used in Pharmaceutical Development:
(4-Fluorobenzyl)phosphonic acid diethyl ester holds potential in the medical field, particularly in the research and development of new drugs and pharmaceuticals, owing to its unique molecular structure and reactivity.

InChI:InChI=1/C11H16FO3P/c1-3-14-16(13,15-4-2)9-10-5-7-11(12)8-6-10/h5-8H,3-4,9H2,1-2H3

Upstream product

• 122-52-1 triethyl phosphite 
• 352-11-4 1-chloromethyl-4-fluorobenzene 
• 762-04-9 phosphonic acid diethyl ester 
• 459-46-1 4-Fluorobenzyl bromide 
• 1067-71-6 Diethyl (2-oxopropyl)phosphonate 
• 352-34-1 4-fluoro-1-iodobenzene 
• 459-56-3 4-fluorobenzylic alcohol 
• 459-57-4 4-fluorobenzaldehyde 
• 210422-66-5 4-fluorobenzaldehyde p-toluenesulfonylhydrazone 

Downstream Products

• 364046-30-0 (diethoxy-phosphoryl)-(4-fluoro-phenyl)-acetic acid 
• 405-86-7 (E)-4-(4-fluorostyryl)-N,N-dimethylaniline 
• 193357-62-9 1-benzyl-4-(4-fluorobenzylidene)piperidine 
• 848487-63-8 (E)-1-methoxymethyloxy-3-(4-fluoro)styrylbenzene 
• 718-25-2 (E)-4-fluorostilbene 
• 588-56-7 (E)-1,2-di(4-fluorophenyl)ethene 
• 798-59-4 tris-(4-fluoro-phenyl)-ethene 
• 128587-92-8 3-[(E)-2-(4-Fluoro-phenyl)-vinyl]-pyridine 
• 117685-85-5 E-4-[2-(4-fluoro-phenyl)-ethenyl]-pyridine 

Relevant articles and documents

Selective hydrolysis of phosphorus(v) compounds to form organophosphorus monoacids

An azide and transition metal-free method for the synthesis of elusive phosphonic, phosphinic, and phosphoric monoacids has been developed. Inert pentavalent P(v)-compounds (phosphonate, phosphinate, and phosphate) are activated by triflate anhydride (Tf2O)/pyridine system to form a highly reactive phosphoryl pyridinium intermediate that undergoes nucleophilic substitution with H2O to selectively deprotect one alkoxy group and form organophosphorus monoacids.

Vinyl-Stilbene Compounds and Uses Thereof

The present invention relates to a biphenyl - stilbene (Vinyl-stilbene) - based compound and a pharmaceutical composition for preventing or treating norovirus infection comprising the same as an active ingredient. The present invention can be usefully used as a pharmaceutical composition for treating norovirus infection by showing superior norovirus inhibitory activity and lower cell toxicity as compared to previously known compounds.

The development of HEC-866 and its analogues for the treatment of idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease with a typical survival time between three to five years. Two drugs, pirfenidone and nintedanib have been approved for the treatment of IPF, but they have limited efficacy. Thus, th

Determination and application of the excited-state substituent constants of pyridyl and substituted phenyl groups

Thirty six 1-pyridyl-2-arylethenes XCH=CHArY (abbreviated XAEY) were synthesized, in which, X is 2-pyridyl, 3-pyridyl and 4-pyridyl and Y is OMe, Me, H, Br, Cl, F, CF3, and CN. Their ultraviolet absorption spectra were measured in anhydrous ethanol, and their wavelengths of absorption maximum λmax were recorded. Also, the 234 λmax values of 1-substituted phenyl-2-arylethylene compounds (XAEY, where X is substituted phenyl) were collected. The excited-state substituent constants (Formula presented.) of three pyridyl groups and 23 substituted phenyl groups (total of 26) were obtained by means of curve-fitting method. Taking the λmax values of 358 samples of bi-arylethene derivatives as a data set and 126 samples of bi-aryl Schiff bases (including nine compounds synthesized by this work) as another data set, quantitative correlation analyses were performed by employing the obtained (Formula presented.) as a parameter, and good results were obtained for the two data sets. The reliability of the obtained (Formula presented.) values was verified. The results of this paper can provide excited-state substituent constants for the study and application of optical properties of conjugated organic compounds containing aryl groups.

Novel compounds useful as fluorescent probes selectively binding to tau aggregates and preparation method thereof

A compound having high selectivity for tau aggregates and a method for preparing the same. The present invention relates to a tau targeting fluorescent probe including the compound, a composition for detecting tau fiber protein comprising the fluorescent

SMALL MOLECULE AUTOPHAGY INDUCERS FOR THE TREATMENT OF CANCER AND NEURODEGENERATIVE DISEASES

Disclosed herein are compounds and methods for treating cancer and neurodegenerative diseases. In some examples, the compounds increase autophagy.

Transition metal-free access to 3,4-dihydro-1,2-oxaphosphinine-2-oxides from phosphonochloridates and chalcones through tandem Michael addition and nucleophilic substitution

A novel and transition metal-free synthesis of 3,4-dihydro-1,2-oxaphosphinine 2-oxides was developed. LiHMDS-mediated tandem Michael addition and nucleophilic substitution of readily available phosphonochloridates and chalcones afforded a variety of valuable 3,4-dihydro-1,2-oxaphosphinine 2-oxides bearing diverse functionalities in excellent yields and satisfactory to good diastereoselectivity (up to 99% yield and up to 99?:?1 dr).

Identification of novel non-nucleoside vinyl-stilbene analogs as potent norovirus replication inhibitors with a potential host-targeting mechanism

Norovirus (NV), is the most common cause of acute gastroenteritis worldwide. To date, there is no specific anti-NV drug or vaccine to treat NV infections. In this study, we evaluated the inhibitory effect of different stilbene-based analogs on RNA genome replication of human NV (HNV) using a virus replicon-bearing cell line (HG23). Initial screening of our in-house chemical library against NV led to the identification of a hit containing stilbene scaffold 5 which on initial optimization gave us a vinyl stilbene compound 16c (EC50 = 4.4 μM). Herein we report our structure-activity relationship study of the novel series of vinyl stilbene analogs that inhibits viral RNA genome replication in a human NV-specific manner. Among these newly synthesized compounds, several amide derivatives of vinyl stilbenes exhibited potent anti-NV activity with EC50 values ranging from 1 to 2 μM. A trans-vinyl stilbenoid with an appended substituted piperazine amide (18k), exhibited potent anti-NV activity and also displayed favorable metabolic stability. Compound 18k demonstrated an excellent safety profile, the highest suppressive effect, and was selective for HNV replication via a viral RNA polymerase-independent manner. Its potential host-targeting antiviral mechanism was further supported by specific activation of heat shock factor 1-dependent stress-inducible pathway by 18k. These results suggest that 18k might be a promising lead compound for developing novel NV inhibitors with the novel antiviral mechanism.

Alcohol-based Michaelis-Arbuzov reaction: An efficient and environmentally-benign method for C-P(O) bond formation

The famous Michaelis-Arbuzov reaction is extensively used both in the laboratory and industry to manufacture tons of widely-used organophosphoryl compounds every year. However, this method and the modified Michaelis-Arbuzov reactions developed recently still have some limitations. We now report a new alcohol-version of the Michaelis-Arbuzov reaction that can provide an efficient and environmentally-benign method to address the problems of the known Michaelis-Arbuzov reactions. That is, a wide range of alcohols can readily react with phosphites, phosphonites, and phosphinites to give all the three kinds of phosphoryl compounds (phosphonates, phosphinates, and phosphine oxides) using an n-Bu4NI-catalyzed efficient C-P(O) bond formation reaction. This general method can also be easily scaled up and used for further synthetic transformations in one pot.

Trihalogen substituted triphenylethylene photochromic materials as well as synthesis method and application thereof

The invention discloses trihalogen substituted triphenylethylene photochromic materials as well as a synthesis method and an application thereof. The materials have the advantages that the photochromic response speed is ultrahigh, the synthesis steps as s